FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Francine Jotereau

Research Profile

Disorders

Melanoma

Chemicals & Drugs

Anatomy

Physiology

Procedures

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Céline Bossard; Francine Jotereau; Christian L Laboisse; Tamara Matysiak-Budnik; Stéphane Bézieau; Christelle Volteau; Jean-François Mosnier
HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression.
Francine Jotereau; Nadine Gervois; Nathalie Labarrière
Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?
Joë-Marc Chauvin; Juliette Desfrançois; Nathalie Labarrière; Pierre Larrieu; Renée Lengagne; Armelle Prévost-Blondel; Guillaume Sarrabayrouse; Francine Jotereau
HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Francine Jotereau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Céline Bossard; Francine Jotereau; Christian L Laboisse; Tamara Matysiak-Budnik; Stéphane Bézieau; Christelle Volteau; Jean-François Mosnier
HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression.
International journal of cancer. Journal international du cancer 2012;131(4):855-63.
2012: Francine Jotereau; Nadine Gervois; Nathalie Labarrière
Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?
Targeted oncology 2012;7(1):3-14.
2012: Joë-Marc Chauvin; Juliette Desfrançois; Nathalie Labarrière; Pierre Larrieu; Renée Lengagne; Armelle Prévost-Blondel; Guillaume Sarrabayrouse; Francine Jotereau
HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(5):2102-10.
2011: Guillaume Sarrabayrouse; Murielle Corvaisier; Laure-Hélène Ouisse; Céline Bossard; Lucien Potiron; Guillaume Meurette; Nadine Gervois; Bernard Le Mével; Francine Jotereau
Tumor-reactive CD4+ CD8αβ+ CD103+ αβT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers.
International journal of cancer. Journal international du cancer 2011;128(12):2923-32.
2011: Emmanuelle Godefroy; Olivier Manches; Brigitte Dréno; Tsivia Hochman; Linda Rolnitzky; Nathalie Labarrière; Yannick Guilloux; Judith Goldberg; Francine Jotereau; Nina Bhardwaj
Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway.
Cancer cell 2011;19(3):333-46.
2010: Céline Douat-Casassus; Oleg Borbulevych; Marion Tarbe; Nadine Gervois; Francine Jotereau; Brian M Baker; Stéphane Quideau
Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition.
Journal of medicinal chemistry 2010;53(19):7061-6.
2010: yann godet; Juliette Desfrançois; Virginie Vignard; Dirk Schadendorf; Amir Khammari; Brigitte Dreno; Francine Jotereau; Nathalie Labarrière
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.
European journal of immunology 2010;40(6):1786-94.
2010: yann godet; Agnès Moreau-Aubry; Dimitri Mompelat; Virginie Vignard; Amir Khammari; Brigitte Dreno; Francois Lang; Francine Jotereau; Nathalie labarriere
An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.
Cancer immunology, immunotherapy : CII 2010;59(3):431-9.
2010: Virginie Renaud; Emmanuelle Godefroy; Pierre Larrieu; Fabrice Fleury; Francine Jotereau; Yannick Guilloux
Folding of matrix metalloproteinase-2 prevents endogenous generation of MHC class-I restricted epitope.
PloS one 2010;5(7):e11894.
2010: Juliette Desfrançois; Agnès Moreau-Aubry; Virginie Vignard; yann godet; Amir Khammari; Brigitte Dréno; Francine Jotereau; Nadine Gervois
Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas.
PloS one 2010;5(1):e8437.
2009: Amir Khammari; Nathalie Labarrière; Virginie Vignard; Jean-Michel Nguyen; Marie-Christine Pandolfino; Anne C Knol; Gaëlle Quéreux; Soraya Saiagh; Anabelle Brocard; Francine Jotereau; Brigitte Dreno
Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.
The Journal of investigative dermatology 2009;129(12):2835-42.
2009: Juliette Desfrançois; Laurent Derré; Murielle Corvaisier; Bernard Le Mével; Véronique Catros; Francine Jotereau; Nadine Gervois
Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions.
International journal of cancer. Journal international du cancer 2009;125(2):374-80.
2009: Régis Bouquié; Annabelle Bonnin; Karine Bernardeau; Amir Khammari; Brigitte Dréno; Francine Jotereau; Nathalie Labarrière; François Lang
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes.
Cancer immunology, immunotherapy : CII 2009;58(4):553-66.
2009: Florence Faure; Adriana Mantegazza; Charlotte Sadaka; Christine Sedlik; Francine Jotereau; Sebastian Amigorena
Long-lasting cross-presentation of tumor antigen in human DC.
European journal of immunology 2009;39(2):380-90.
2009: yann godet; Annabelle Bonnin; Yannik Guilloux; Virginie Vignard; Dirk Schadendorf; Brigitte Dreno; Francine Jotereau; Nathalie Labarriere
A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients.
Cancer immunology, immunotherapy : CII 2009;58(2):271-80.
2008: yann godet; Agnès Moreau-Aubry; Yannik Guilloux; Virginie Vignard; Amir Khammari; Brigitte Dreno; Francine Jotereau; Nathalie Labarriere
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
The Journal of experimental medicine 2008;205(11):2673-82.
2008: Matthieu Le Gallo; Olivier Toutirais; Tristan Montier; Florian Cabillic; Françoise Bouet; Pascal Delépine; Pierre Lehn; Francine Jotereau; Véronique Catros
Activation of tumor-specific T cells by dendritic cells expressing the NY-ESO-1 antigen after transfection with the cationic lipophosphoramide KLN5.
The journal of gene medicine 2008;10(6):628-36.
2008: Pierre Larrieu; Virginie Renaud; yann godet; Francine Jotereau; Jean-François Fonteneau
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes.
Cancer immunology, immunotherapy : CII 2008;57(5):745-52.
2008: Nathalie Labarrière; Nadine Gervois; Annabelle Bonnin; Régis Bouquié; Francine Jotereau; François Lang
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting.
Cancer immunology, immunotherapy : CII 2008;57(2):185-95.
2007: Amir Khammari; Jean-Michel Nguyen; Marie-Christine Pandolfino; Gaëlle Quereux; Anabelle Brocard; Sylvain Bercegeay; Alain Cassidanius; Philippe Lemarre; Christelle Volteau; Nathalie Labarrière; Francine Jotereau; Brigitte Dréno
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
Cancer immunology, immunotherapy : CII 2007;56(11):1853-60.
2007: Pierre Larrieu; Laure-Hélène Ouisse; Yannick Guilloux; Francine Jotereau; Jean-François Fonteneau
A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes.
Cancer immunology, immunotherapy : CII 2007;56(10):1565-75.
2007: Oruganti Srinivas; Pierre Larrieu; Eric Duverger; Claire Boccaccio; Marie-Thérèse Bousser; Michel Monsigny; Jean-François Fonteneau; Francine Jotereau; Annie-Claude Roche
Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting.
Bioconjugate chemistry 2007;18(5):1547-54.
2007: Céline Douat-Casassus; Nathalie Marchand-Geneste; Elisabeth Diez; Nadine Gervois; Francine Jotereau; Stéphane Quideau
Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.
Journal of medicinal chemistry 2007;50(7):1598-609.
2007: Houssem Benlalam; Virginie Vignard; Amir Khammari; Annabelle Bonnin; yann godet; Marie-Christine Pandolfino; Francine Jotereau; Brigitte Dreno; Nathalie Labarrière
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients.
Cancer immunology, immunotherapy : CII 2007;56(4):515-26.
2006: Emmanuelle Godefroy; Luigi Scotto; Naira E Souleimanian; Gerd Ritter; Lloyd J Old; Francine Jotereau; Danila Valmori; Maha Ayyoub
Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles.
Clinical immunology (Orlando, Fla.) 2006;121(1):54-62.
2006: Laurent Derré; Murielle Corvaisier; Béatrice Charreau; Anne Moreau; Emmanuelle Godefroy; Agnès Moreau-Aubry; Francine Jotereau; Nadine Gervois
Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(5):3100-7.
2006: Céline Douat-Casassus; Nathalie Marchand-Geneste; Elisabeth Diez; Céline Aznar; Philippe Picard; Serge Geoffre; Aline Huet; Marie-Lise Bourguet-Kondracki; Nadine Gervois; Francine Jotereau; Stéphane Quideau
Covalent modification of a melanoma-derived antigenic peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies.
Molecular bioSystems 2006;2(5):240-9.
2005: Murielle Corvaisier; Agnès Moreau-Aubry; Elisabeth Diez; Jaafar Bennouna; Jean-Francois Mosnier; Emmanuel Scotet; Marc Bonneville; Francine Jotereau
V gamma 9V delta 2 T cell response to colon carcinoma cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(8):5481-8.
2005: Virginie Vignard; Brigitte Lemercier; Annick Lim; Marie-Christine Pandolfino; Yannick Guilloux; Amir Khammari; Catherine Rabu; Klara Echasserieau; François Lang; Marie-lise GOUGEON; Brigitte Dreno; Francine Jotereau; Nathalie Labarriere
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(7):4797-805.
2005: Emmanuelle Godefroy; Agnès Moreau-Aubry; Elisabeth Diez; Brigitte Dreno; Francine Jotereau; Yannick Guilloux
alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen.
The Journal of experimental medicine 2005;202(1):61-72.
2004: Olivier Faure; Stéphanie Graff-Dubois; Laurent Bretaudeau; Laurent Derré; David-Alexandre Gross; Pedro M S Alves; Sébastien Cornet; Marie-Thérèse Duffour; Salem Chouaib; Isabelle Miconnet; Marc Grégoire; Francine Jotereau; François A Lemonnier; Jean-Pierre Abastado; Kostas Kosmatopoulos
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes.
International journal of cancer. Journal international du cancer 2004;108(6):863-70.
2003: Houssem Benlalam; Boris Linard; Yannick Guilloux; Agnès Moreau-Aubry; Laurent Derré; Elisabeth Diez; Brigitte Dreno; Francine Jotereau; Nathalie Labarrière
Identification of five new HLA-B*3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumor-infiltrating lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(11):6283-9.
2003: Francine Jotereau; Nathalie Labarriere; Nadine Gervois; Marie-Christine Pandolfino; Brigitte Dreno
[Passive immunotherapy of melanoma].
Bulletin du cancer 2003;90(7):583-6.
2003: Pierre-Yves Dietrich; Frédérique-Anne Le Gal; Valérie Dutoit; Mikaël J Pittet; Lydie Trautman; Alfred Zippelius; Isabelle Cognet; Valérie Widmer; Paul R Walker; Olivier Michielin; Philippe Guillaume; Thierry Connerotte; Francine Jotereau; Pierre G Coulie; Pedro Romero; Jean-Charles Cerottini; Marc Bonneville; Danila Valmori
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(10):5103-9.
2003: Francine Jotereau; Nathalie Labarrière; Nadine Gervois; Marie-Christine Pandolfino; Brigitte Dreno
[Adoptive immunotherapy in solid tumors: new hope].
Médecine sciences : M/S 2003;19(3):268-70.
2002: Lydie Trautmann; Nathalie Labarrière; Francine Jotereau; VAIOS KARANIKAS; Nadine Gervois; Thierry Connerotte; Pierre G Coulie; Marc Bonneville
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens.
European journal of immunology 2002;32(11):3181-90.
2002: Brigitte Dréno; Jean-Michel Nguyen; Amir Khammari; Marie-Christine Pandolfino; Marie-Hélène Tessier; Sylvain Bercegeay; Alain Cassidanius; Philippe Lemarre; Sylviane Billaudel; Nathalie Labarrière; Francine Jotereau
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
Cancer immunology, immunotherapy : CII 2002;51(10):539-46.
2002: Nathalie Labarrière; Marie-Christine Pandolfino; Nadine Gervois; Amir Khammari; Marie-Hélène Tessier; Brigitte Dréno; Francine Jotereau
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients.
Cancer immunology, immunotherapy : CII 2002;51(10):532-8.
2002: Nathalie Labarrière; Laurent Bretaudeau; Nadine Gervois; Marie Bodinier; Gwenola Bougras; Elisabeth Diez; François Lang; Marc Gregoire; Francine Jotereau
Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen.
International journal of cancer. Journal international du cancer 2002;101(3):280-6.
2002: Laurent Derré; Murielle Corvaisier; Marie-Christine Pandolfino; Elisabeth Diez; Francine Jotereau; Nadine Gervois
Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(10):4864-70.
2002: Boris Linard; Stéphane Bézieau; Houssem Benlalam; Nathalie Labarrière; Yannick Guilloux; Elisabeth Diez; Francine Jotereau
A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4802-8.
2001: Jean-François Fonteneau; Marie Larsson; Selin Somersan; Catherine Sanders; Christian Münz; W W Kwok; Nina Bhardwaj; Francine Jotereau
Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells.
Journal of immunological methods 2001;258(1-2):111-26.
2001: Houssem Benlalam; Nathalie Labarrière; Boris Linard; Laurent Derré; Elisabeth Diez; Marie-Christine Pandolfino; Marc Bonneville; Francine Jotereau
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy.
European journal of immunology 2001;31(7):2007-15.
2001: Marie-Christine Pandolfino; Nathalie Labarrière; Marie-Hélène Tessier; Alain Cassidanius; Sylvain Bercegeay; Philippe Lemarre; F Dehaut; Brigitte Dréno; Francine Jotereau
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement.
Cancer immunology, immunotherapy : CII 2001;50(3):134-40.
2000: Agnès Moreau-Aubry; S Le Guiner; Nathalie Labarrière; Marie-Claude Gesnel; Francine Jotereau; Richard Breathnach
A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma.
The Journal of experimental medicine 2000;191(9):1617-24.
2000: Nadine Gervois; Nathalie Labarriere; S Le Guiner; Marie-Christine Pandolfino; Jean-François Fonteneau; Yannick Guilloux; Elisabeth Diez; Brigitte Dreno; Francine Jotereau
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1459-67.
2000: Catherine Pellat-Deceunynck; Marie-Paule Mellerin; Nathalie Labarrière; G Jego; Agnès Moreau-Aubry; Jean-Luc Harousseau; Francine Jotereau; Régis Bataille
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
European journal of immunology 2000;30(3):803-9.
1999: Danila Valmori; Jean-François Fonteneau; Salvatore Valitutti; Nadine Gervois; R Dunbar; Danielle Liénard; Donata Rimoldi; Vincenzo Cerundolo; Francine Jotereau; Jean-Charles Cerottini; Daniel E Speiser; Pedro Romero
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
International immunology 1999;11(12):1971-80.
1999: C Ibisch; Géraldine Gallot; Régine Vivien; Elisabeth Diez; Francine Jotereau; R Garand; Henri Vié
Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation.
Bone marrow transplantation 1999;23(11):1153-9.
1998: Danila Valmori; Nadine Gervois; Donata Rimoldi; Jean-François Fonteneau; Anilza Bonelo; Danielle Liénard; L Rivoltini; Francine Jotereau; Jean-Charles Cerottini; Pedro Romero
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):6956-62.
1998: Nathalie Labarriere; Marie-Christine Pandolfino; D Raingeard; S Le Guiner; Elisabeth Diez; E Le Dréan; Brigitte Dreno; Francine Jotereau
Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes.
International journal of cancer. Journal international du cancer 1998;78(2):209-15.
1998: S Le Guiner; E Le Dréan; Nathalie Labarrière; Jean-François Fonteneau; C Viret; Elisabeth Diez; Francine Jotereau
LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal.
European journal of immunology 1998;28(4):1322-31.
1998: Danila Valmori; Jean-François Fonteneau; C M Lizana; Nadine Gervois; Danielle Liénard; Donata Rimoldi; Victor Jongeneel; Francine Jotereau; Jean-Charles Cerottini; Pedro Romero
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1750-8.
1998: E Le Dréan; Frédéric Vély; L Olcese; A Cambiaggi; S Guia; G Krystal; Nadine Gervois; Alessandro Moretta; Francine Jotereau; Eric Vivier
Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases.
European journal of immunology 1998;28(1):264-76.
1997: Jean-François Fonteneau; E Le Dréan; S Le Guiner; Nadine Gervois; Elisabeth Diez; Francine Jotereau
Heterogeneity of biologic responses of melanoma-specific CTL.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2831-9.
1997: Pedro Romero; Nadine Gervois; Joerg Schneider; P Escobar; Danila Valmori; C Pannetier; A Steinle; T Wolfel; Danielle Lienard; Vincent G Brichard; Aline Van Pel; Francine Jotereau; Jean-Charles Cerottini
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(5):2366-74.
1997: L Toujas; J G Delcros; Elisabeth Diez; Nadine Gervois; G Semana; G Corradin; Francine Jotereau
Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides.
Immunology 1997;91(4):635-42.
1997: Nathalie Labarriere; Elisabeth Diez; Marie-Christine Pandolfino; C Viret; Yannick Guilloux; S Le Guiner; Jean-François Fonteneau; Brigitte Dreno; Francine Jotereau
Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(3):1238-45.
1996: Nadine Gervois; Y Guilloux; Elisabeth Diez; Francine Jotereau
Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions.
The Journal of experimental medicine 1996;183(5):2403-7.
1996: Marie-Hélène Tessier; Marie-Christine Pandolfino; Francine Jotereau; D Boudart; P Litoux; Brigitte Dréno
Home therapy with autologous tumour-infiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(4):735-6.
1996: Y Guilloux; S Lucas; Vincent G Brichard; Aline Van Pel; C Viret; Etienne De Plaen; Francis Brasseur; Bernard Lethé; Francine Jotereau; Thierry Boon
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.
The Journal of experimental medicine 1996;183(3):1173-83.
1995: C Viret; Nadine Gervois; Y Guilloux; E Le Dréan; Elisabeth Diez; Francine Jotereau
T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro.
International immunology 1995;7(10):1535-43.
1995: E Le Dréan; Nadine Gervois; Elisabeth Diez; G Semana; Brigitte Dreno; Francine Jotereau
HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes.
European journal of immunology 1995;25(10):2732-6.
1995: A Choudhary; François Davodeau; A Moreau; Marie-Alix Peyrat; Marc Bonneville; Francine Jotereau
Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(8):3932-40.
1994: Isabelle Puisieux; Jos Even; C Pannetier; Francine Jotereau; Marie-Christine Favrot; Philippe Kourilsky
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(6):2807-18.
1994: Y Guilloux; C Viret; Nadine Gervois; E Le Dréan; Marie-Christine Pandolfino; Elisabeth Diez; Francine Jotereau
Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
European journal of immunology 1994;24(9):1966-73.
1993: C Viret; François Davodeau; Y Guilloux; J D Bignon; G Semana; Richard Breathnach; Francine Jotereau
Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.
European journal of immunology 1993;23(1):141-6.
1992: F Heuze; Drew M Pardoll; Elisabeth Diez; S Ezine; Francine Jotereau
Molecular analysis of a pro-T cell clone transformed by Abelson-murine leukemia virus, displaying progressive gamma delta T cell receptor gene rearrangement and surface expression.
European journal of immunology 1992;22(8):2077-84.
1992: Marie-Christine Pandolfino; C Viret; Nadine Gervois; Y Guilloux; François Davodeau; Elisabeth Diez; Francine Jotereau
Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
European journal of immunology 1992;22(7):1795-802.
1991: Francine Jotereau; Marie-Christine Pandolfino; D Boudart; Elisabeth Diez; Brigitte Dreno; J Y Douillard; J Y Muller; B LeMevel
High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(6):405-11.
1990: Nadine Gervois; F Heuze; Elisabeth Diez; Francine Jotereau
High proliferative capacity and specific antiautologous melanoma cytotoxicity of a human T-lymphocyte clone derived from tumor-infiltrating lymphocytes.
Human immunology 1990;28(2):112-8.
1990: Nadine Gervois; F Heuze; Elisabeth Diez; Francine Jotereau
Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
European journal of immunology 1990;20(4):825-31.
1987: D Aubert; F Heuze; Elisabeth Diez; Francine Jotereau; R Berger
Cytogenetics of Abelson virus-induced malignant lymphoma cell lines in the mouse.
Cancer genetics and cytogenetics 1987;28(1):119-25.
1987: Francine Jotereau; F Heuze; V Salomon-Vie; H Gascan
Cell kinetics in the fetal mouse thymus: precursor cell input, proliferation, and emigration.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(4):1026-30.
1985: Elisabeth Houssaint; E Diez; Francine Jotereau
Tissue distribution and ontogenic appearance of a chicken T lymphocyte differentiation marker.
European journal of immunology 1985;15(3):305-8.
1980: Francine Jotereau; Elisabeth Houssaint; N M Le Douarin
Lymphoid stem cell homing to the early thymic primordium of the avian embryo.
European journal of immunology 1980;10(8):620-7.